Redmond Asset Management’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,560
| Closed | -$42.3K | – | 161 |
|
|
2024
Q1 | $42.3K | Sell |
19,560
-84
| -0.4% | -$181 | 0.01% | 150 |
|
|
2023
Q4 | $24.9K | Sell |
19,644
-1,333
| -6% | -$1.69K | 0.01% | 157 |
|
|
2023
Q3 | $29.2K | Buy |
20,977
+1
| +0% | +$1 | 0.01% | 159 |
|
|
2023
Q2 | $75.7K | Buy |
20,976
+8
| +0% | +$29 | 0.02% | 157 |
|
|
2023
Q1 | $82.7K | Hold |
20,968
| – | – | 0.03% | 161 |
|
|
2022
Q4 | $62.9K | Buy |
20,968
+555
| +3% | +$1.67K | 0.02% | 166 |
|
|
2022
Q3 | $111K | Sell |
20,413
-34
| -0.2% | -$185 | 0.04% | 165 |
|
|
2022
Q2 | $91K | Hold |
20,447
| – | – | 0.03% | 181 |
|
|
2022
Q1 | $182K | Buy |
+20,447
| New | +$182K | 0.05% | 182 |
|